← Back to Search

Fuerte Program for Psychological Trauma in Immigrant Youth (Fuerte Trial)

N/A
Waitlist Available
Led By William Martinez, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
12 to 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately before intervention, immediately after intervention, and 3-months post intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial will test the efficacy of a school-based group prevention program called Fuerte, which is designed to help newcomer Latinx immigrant youth who are at risk of experiencing traumatic stress. The program will be implemented by mental health providers from various county community-based organizations, as well as from the SFUSD Wellness Centers.

Who is the study for?
This trial is for newcomer Latinx immigrant youth in San Francisco Unified School District, aged 12-18, who arrived in the U.S. within the last five years and speak Spanish or Arabic fluently. It's aimed at those who haven't completed the Fuerte program before and are at risk of traumatic stress.
What is being tested?
The study tests 'Fuerte,' a school-based group prevention program designed to improve mental health literacy, social functioning, and connect at-risk youth with specialized mental health services. The effectiveness of adapting Fuerte for non-Latin American immigrants will also be assessed.
What are the potential side effects?
Since 'Fuerte' is a psychological support program rather than a medical treatment, it may not have typical side effects; however, discussing emotional topics could potentially cause temporary distress or discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 12 and 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately before intervention, immediately after intervention, and 3-months post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately before intervention, immediately after intervention, and 3-months post intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in linkages to specialty mental health services for at-risk identified youth by the Pediatric Symptom Checklist - 35.
Secondary study objectives
Change in Perceived language ability pressures measured by the Negative Immigrant Community Experience Scale (NICE)
Change in Perceived negative community climate measured by the Negative Immigrant Community Experience Scale (NICE)
Change in perceived experience with discrimination measured by the Negative Immigrant Community Experience Scale (NICE)
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: FuerteExperimental Treatment1 Intervention
This group will receive the Fuerte prevention program over the span of six to eight weeks.
Group II: Delayed waitlist controlActive Control1 Intervention
This group will be the delayed waitlist control group. They will not receive the Fuerte prevention program until the following semester.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,593 Previous Clinical Trials
14,887,550 Total Patients Enrolled
San Francisco Department of Public HealthOTHER_GOV
37 Previous Clinical Trials
35,560 Total Patients Enrolled
William Martinez, PhDPrincipal InvestigatorUniversity of California, San Francisco

Media Library

Fuerte Clinical Trial Eligibility Overview. Trial Name: NCT04156373 — N/A
Teenage angst Research Study Groups: Fuerte, Delayed waitlist control
Teenage angst Clinical Trial 2023: Fuerte Highlights & Side Effects. Trial Name: NCT04156373 — N/A
Fuerte 2023 Treatment Timeline for Medical Study. Trial Name: NCT04156373 — N/A
~44 spots leftby Jun 2025